Stories
Slash Boxes
Comments

SoylentNews is people

posted by Fnord666 on Monday February 26 2018, @10:19AM   Printer-friendly
from the flu-killer dept.

https://www.wsj.com/articles/experimental-drug-promises-to-kill-the-flu-virus-in-a-day-1518264004

As Americans suffer through the worst influenza outbreak in almost a decade, a Japanese drugmaker says it has developed a pill that can kill the virus within a day. But even if the experimental drug lives up to the claim, it likely won't be available in the U.S. until next year at the earliest.

A late-stage trial on Japanese and American flu patients found that for the people who took the Shionogi 4507 1.41% & Co. compound, the median time taken to wipe out the virus was 24 hours. That is much quicker than any other flu drug on the market, including Roche AG's RHHBY -0.34% Tamiflu, which the trial showed took three times longer to achieve the same result. Quickly killing the virus could reduce its contagious effects, Shionogi said.

Also, Shionogi's experimental drug requires only a single dose, while patients need to take two doses of Tamiflu a day, for five days.

Both Shionogi's compound and Tamiflu take roughly the same amount of time to entirely contain flu symptoms, but Shionogi says its compound provides immediate relief faster.


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 1) by tftp on Monday February 26 2018, @07:01PM (1 child)

    by tftp (806) on Monday February 26 2018, @07:01PM (#644094) Homepage
    To discover a few years later that one of the the treatments has a small side effect - death, for example. And all humans on Earth had been treated.
  • (Score: 2) by sgleysti on Wednesday February 28 2018, @03:29AM

    by sgleysti (56) Subscriber Badge on Wednesday February 28 2018, @03:29AM (#644945)

    This can be easily remedied by testing the treatment on less than 100% of the population first.